Holen Sie sich die Stockscreener-App
376.25
0.02%
-0.15
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$376.40
Offen:
$376.01
24-Stunden-Volumen:
347.88K
Relative Volume:
0.20
Marktkapitalisierung:
$81.60B
Einnahmen:
$201.11B
Nettoeinkommen (Verlust:
$4.95B
KGV:
16.72
EPS:
22.4991
Netto-Cashflow:
$6.29B
1W Leistung:
-0.36%
1M Leistung:
-2.69%
6M Leistung:
+8.84%
1J Leistung:
+32.93%
1-Tages-Spanne:
$373.16
$380.04
1-Wochen-Bereich:
$362.98
$388.73
52-Wochen-Spanne:
$273.71
$436.24
Elevance Health Inc Stock (ELV) Company Profile
Firmenname
Elevance Health Inc
Sektor
Branche
Telefon
(800) 331-1476
Adresse
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
376.25 | 82.05B | 201.11B | 4.95B | 6.29B | 22.50 |
UNH
Unitedhealth Group Inc
|
418.18 | 379.28B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
105.14 | 136.61B | 407.94B | 2.90B | 7.39B | 2.2771 |
CI
Cigna Group
|
282.40 | 76.98B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
365.51 | 45.76B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-08 | Eingeleitet | Evercore ISI | In-line |
| 2026-02-03 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-19 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-07-21 | Herabstufung | Argus | Buy → Hold |
| 2025-07-18 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Hochstufung | Argus | Hold → Buy |
| 2025-01-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Herabstufung | Argus | Buy → Hold |
| 2024-07-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
Alle ansehen
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
AE1N Bond Profile — Key Metrics - TradingView
Elevance Health, Inc. (ELV) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health, Inc. (ELV) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health, Inc. (ELV) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
President of Elevance Health Gail Boudreaux Buys 1.9% More Shares - simplywall.st
Elevance Health, Inc. (ELV) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health, Inc. (ELV) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health, Inc. (ELV) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health stock holds on earnings and guidance - AD HOC NEWS
Elevance Health Inc (ELV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Elevance Health Market Sentiment - Benzinga España
Elevance Health, Inc. (A58) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health stock trades steadily as recent earnings highlight Medicaid growth and margin resili - AD HOC NEWS
ELV|Elevance Health Inc|Price:377.680|Chg%:-1.870 - TradingKey
AE1H Bond Profile — Key Metrics - TradingView
Elevance Health, Inc. (A58) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health, Inc. (A58) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
AE1P Bond Profile — Key Metrics - TradingView
Vanguard Windsor II Fund's Elevance Health Inc(ELV) Holding History - GuruFocus
Elevance Health (ELV) Stock Still Looks Reasonable After A 43% Run - Yahoo Finance
Elevance Health stock trades steadily as earnings and Medicare growth shape investor focus - Ad-hoc-news.de
Elevance Health Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
The Hidden Engine Behind Elevance Health Stock's Next Climb - Trefis
Elevance Health stock trades steadily as earnings and Medicaid growth shape investor focus - Ad-hoc-news.de
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Elevance Health Inc Stock Price Live, Charts & News - The Economic Times
Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now? - The Motley Fool
AE1D Bond Profile — Key Metrics - TradingView
AE1J Bond Profile — Key Metrics - TradingView
Elevance Health President Acquires 1.9% More Stock - Moomoo
Elevance Health director Peru buys $366,050 in company stock - Investing.com UK
Elevance Preparing to Exit Several Medicaid States - RamaOnHealthcare
Elevance Health CEO Gail Boudreaux acquires common shares worth $1,003,428.45 - Bitget
Elevance Health Price Target Raised to $395.00/Share From $364.00 by Leerink Partners - Moomoo
Insider Buying: Ramiro Peru Acquires Shares of Elevance Health I - GuruFocus
Elevance Health CEO Snaps Up Stock After Post-Earnings Slide - Barron's
Elevance Health director Peru buys $366,050 in company stock By Investing.com - Investing.com South Africa
Elevance Health, Inc. $ELV Shares Acquired by Bank of New York Mellon Corp - InsuranceNewsNet
What's a Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets? - Trefis
Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook? - The Motley Fool
Elevance Health (NYSE: ELV) director purchases 1,000 shares at $366 - Stock Titan
Form 4 Elevance Health Inc For: 17 July By Investing.com - Investing.com South Africa
Elevance Health (NYSE: ELV) CEO Gail Boudreaux purchases 2,725 shares - Stock Titan
Elevance Health CEO Gail Boudreaux buys $1.0m in company stock By Investing.com - Investing.com Australia
Elevance Health CEO Gail Boudreaux buys $1.0m in company stock - Investing.com Nigeria
Leerink Partners Adjusts PT on Elevance Health to $395 From $364, Maintains Market Perform Rating - Moomoo
Bernstein Adjusts Price Target on Elevance Health to $488 From $482, Maintains Outperform Rating - Moomoo
Leerink Partners Maintains Elevance Health(ELV.US) With Hold Rating, Raises Target Price to $395 - Moomoo
Elevance Health's Strong Q2 Prompts Higher 2026-27 Estimates, Truist Says - Moomoo
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV) and Pfizer (PFE) - The Globe and Mail
These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings - Sahm
Finanzdaten der Elevance Health Inc-Aktie (ELV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Elevance Health Inc-Aktie (ELV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BOUDREAUX GAIL | President and CEO |
Jul 17 '26 |
Buy |
367.79 |
2,725 |
1,002,230 |
171,976 |
1.70%
1.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):